phase ii animate trial investigating pet response-adapted treatment using nivolumab in r/r chl
Published 3 months ago • 83 plays • Length 2:02Download video MP4
Download video MP3
Similar videos
-
1:44
updates from the phase ii animate trial of nivolumab in r/r chl
-
4:22
accelerated-phase mpns: pathophysiology, treatment approaches and ongoing clinical trials
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:39
phase i/ii trial of adct-602 in b-all
-
4:44
7-year update on a phase ii trial of fixed-duration obinutuzumab, ibrutinib, and venetoclax for cll
-
3:56
results of the phase ii titan study of caplacizumab in patients with attp
-
4:53
revisiting clinical trial design – more adaptability in phase i – iii?
-
2:14
risk-adapted treatment of et & pv
-
3:13
targeting cd38 with a bispecific antibody to treat r/r aml: a phase i trial
-
2:19
insights into the phase iia mylox-1 trial: assessing efficacy of gb2064 in myelofibrosis
-
2:20
airways-2 trial results animation
-
4:48
an insight into the management of cytopenias in mf
-
4:58
findings of a phase i study of anitocabtagene autoleucel for the treatment of r/r myeloma
-
1:52
safety and efficacy of idasanutlin in pv
-
1:35
novel mutations in pv & the importance of understanding their role in disease initiation
-
3:28
a phase ib trial of fixed-volume isatuximab infusion in newly-diagnosed multiple myeloma
-
3:46
the impact of cytogenetic risk on outcomes of haploidentical transplantation in r/r aml
-
1:05
cinematic rendering animation of an hepatobiliary tumor
-
1:34
invitrogen primary conjugated antibody—a flow cytometry artist